225 related articles for article (PubMed ID: 15781212)
21. Influence of CYP1A1, GSTM1, GSTT1, and NQO1 genotypes and cumulative smoking dose on lung cancer risk in a Swedish population.
Alexandrie AK; Nyberg F; Warholm M; Rannug A
Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):908-14. PubMed ID: 15184245
[TBL] [Abstract][Full Text] [Related]
22. Genetic variants in SOD2, MPO, and NQO1, and risk of ovarian cancer.
Olson SH; Carlson MD; Ostrer H; Harlap S; Stone A; Winters M; Ambrosone CB
Gynecol Oncol; 2004 Jun; 93(3):615-20. PubMed ID: 15196853
[TBL] [Abstract][Full Text] [Related]
23. Association of the NAD(P)H: quinone oxidoreductase C609T polymorphism and the risk of cervical cancer in Japanese subjects.
Niwa Y; Hirose K; Nakanishi T; Nawa A; Kuzuya K; Tajima K; Hamajima N
Gynecol Oncol; 2005 Feb; 96(2):423-9. PubMed ID: 15661231
[TBL] [Abstract][Full Text] [Related]
24. Combinations of the variant genotypes of GSTP1, GSTM1, and p53 are associated with an increased lung cancer risk.
Miller DP; Liu G; De Vivo I; Lynch TJ; Wain JC; Su L; Christiani DC
Cancer Res; 2002 May; 62(10):2819-23. PubMed ID: 12019159
[TBL] [Abstract][Full Text] [Related]
25. [Genetic polymorphisms of MPO, NQO1, GSTP1, UGT1A6 associated with susceptibility of chronic benzene poisoning].
Sun P; Zhang Z; Wan J; Shao M
Wei Sheng Yan Jiu; 2007 Jan; 36(1):11-5. PubMed ID: 17424838
[TBL] [Abstract][Full Text] [Related]
26. Association of DNA repair gene XRCC1 and lung cancer susceptibility among nonsmoking Chinese women.
Yin J; Vogel U; Ma Y; Qi R; Wang H
Cancer Genet Cytogenet; 2009 Jan; 188(1):26-31. PubMed ID: 19061777
[TBL] [Abstract][Full Text] [Related]
27. [Association between NAD(P)H: quinone oxidoreductase and apolipoprotein E gene polymorphisms in Alzheimer's disease].
Ma QL; Yang JF; Shao M; Dong XM; Chen B
Zhonghua Yi Xue Za Zhi; 2003 Dec; 83(24):2124-7. PubMed ID: 14720419
[TBL] [Abstract][Full Text] [Related]
28. GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking.
Schneider J; Bernges U; Philipp M; Woitowitz HJ
Cancer Lett; 2004 May; 208(1):65-74. PubMed ID: 15105047
[TBL] [Abstract][Full Text] [Related]
29. Combined effects of genetic polymorphisms in six selected genes on lung cancer susceptibility.
Yang M; Choi Y; Hwangbo B; Lee JS
Lung Cancer; 2007 Aug; 57(2):135-42. PubMed ID: 17428572
[TBL] [Abstract][Full Text] [Related]
30. Identification of NQO1 and GSTs genotype frequencies in Bulgarian patients with Balkan endemic nephropathy.
Toncheva DI; Von Ahsen N; Atanasova SY; Dimitrov TG; Armstrong VW; Oellerich M
J Nephrol; 2004; 17(3):384-9. PubMed ID: 15365958
[TBL] [Abstract][Full Text] [Related]
31. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
[TBL] [Abstract][Full Text] [Related]
32. No association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and risk of hepatocellular carcinoma development in Turkish subjects.
Akkiz H; Bayram S; Bekar A; Akgöllü E; Ülger Y; Kaya BY; Sandikçi M; Özdil B
Asian Pac J Cancer Prev; 2010; 11(4):1051-8. PubMed ID: 21133623
[TBL] [Abstract][Full Text] [Related]
33. Polymorphisms in the NAD(P)H: quinone oxidoreductase gene and small cell lung cancer risk in a UK population.
Lewis SJ; Cherry NM; Niven RM; Barber PV; Povey AC
Lung Cancer; 2001 Nov; 34(2):177-83. PubMed ID: 11679176
[TBL] [Abstract][Full Text] [Related]
34. [Study on genetic polymorphism of NQO1 and susceptibility to benzene poisoning].
Chen Y; Ji Z; Xu J; Wu C; Li G
Wei Sheng Yan Jiu; 2004 Nov; 33(6):657-9. PubMed ID: 15727169
[TBL] [Abstract][Full Text] [Related]
35. CYP1A1 Val462 and NQO1 Ser187 polymorphisms, cigarette use, and risk for colorectal adenoma.
Hou L; Chatterjee N; Huang WY; Baccarelli A; Yadavalli S; Yeager M; Bresalier RS; Chanock SJ; Caporaso NE; Ji BT; Weissfeld JL; Hayes RB
Carcinogenesis; 2005 Jun; 26(6):1122-8. PubMed ID: 15731166
[TBL] [Abstract][Full Text] [Related]
36. Evidence on the association between NQO1 Pro187Ser polymorphism and breast cancer risk in the current studies: a meta-analysis.
Yuan W; Xu L; Chen W; Wang L; Fu Z; Pang D; Li D
Breast Cancer Res Treat; 2011 Jan; 125(2):467-72. PubMed ID: 20526805
[TBL] [Abstract][Full Text] [Related]
37. Genetic variants of myeloperoxidase and lung cancer risk.
Schabath MB; Spitz MR; Zhang X; Delclos GL; Wu X
Carcinogenesis; 2000 Jun; 21(6):1163-6. PubMed ID: 10837005
[TBL] [Abstract][Full Text] [Related]
38. Association analysis of NAD(P)H:quinone oxidoreductase gene 609 C/T polymorphism with Alzheimer's disease.
Wang B; Jin F; Xie Y; Tang Y; Kan R; Zheng C; Yang Z; Wang L
Neurosci Lett; 2006 Dec; 409(3):179-81. PubMed ID: 17027152
[TBL] [Abstract][Full Text] [Related]
39. Genetic polymorphisms of MPO, COMT, MnSOD, NQO1, interactions with environmental exposures and bladder cancer risk.
Hung RJ; Boffetta P; Brennan P; Malaveille C; Gelatti U; Placidi D; Carta A; Hautefeuille A; Porru S
Carcinogenesis; 2004 Jun; 25(6):973-8. PubMed ID: 14729580
[TBL] [Abstract][Full Text] [Related]
40. Polymorphisms in the NQO1, GSTT and GSTM genes are associated with coronary heart disease and biomarkers of oxidative stress.
Martin NJ; Collier AC; Bowen LD; Pritsos KL; Goodrich GG; Arger K; Cutter G; Pritsos CA
Mutat Res; 2009 Mar; 674(1-2):93-100. PubMed ID: 18950733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
